ABUS Stock Analysis: Buy, Sell, or Hold?
ABUS - Arbutus Biopharma Corporation Common Stock
$4.31
0.00 (0.00%)
▲
5d:
-2.49%
30d:
-0.92%
90d:
+3.61%
BUY
MODERATE Confidence
Analysis Updated: May 13, 2026 12:00 AM ET
Earnings: May 13, 2026
0d
Smart Money Accumulation
ABUS is down 3.3% this week, but smart money is accumulating calls. Top strike: $4 2026-06-18 with 2,012 OI. Call ratio: 100% View Scanner →
Strength: 6.6/10
Get Alerted When ABUS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
3 traders called ABUS this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ABUS shows positive signals but monitor for confirmation. Moderate conviction.
💡 BUY OPPORTUNITY: ABUS shows positive signals but monitor for confirmation. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ABUS is currently trading at $4.31, which is considered fair relative to its 30-day fair value range of $4.22 to $4.51.
Technical Outlook: Technically, ABUS is showing sideways momentum. Immediate support is located at $4.13, while resistance sits at $4.54.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.21 (+20.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ABUS is showing sideways momentum. Immediate support is located at $4.13, while resistance sits at $4.54.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.21 (+20.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$4.22 -
$4.51
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 20.8% below Wall St target ($5.21)
Trading Range Analysis
30-Day Trading Range
$4.22 -
$4.51
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$4.13
Resistance Level
$4.54
Current Trend
Sideways
Technical data as of
May 13, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.25
Wall Street Target
$5.21
(+20.8%)
Revenue Growth (YoY)
-33.2%
Profit Margin
-237.9%
Share & Embed Analysis
Last updated: May 14, 2026 7:54 AM ET
Data refreshes hourly during market hours. Next update: 8:54 AM
Data refreshes hourly during market hours. Next update: 8:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABUS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$23 | 53 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 55 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$73 | 54 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$297 | 59 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 53 HOLD |
Advanced ABUS Option Strategies
Professional options setups generated by AI based on today's ABUS price and gamma walls.
